NCT01390805View on ClinicalTrials.gov

Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis)

CompletedOBSERVATIONAL

Enrollment

462

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2009

Study Completion Date

March 31, 2011

Conditions

Genital Herpes

Interventions

DRUG

Valaciclovir Hydrochloride.

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01390805 - Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis) | Biotech Hunter | Biotech Hunter